Active substance: 1 capsule contains soft low-fat fortified soy phospholipids 300 mg;
Excipients: mono-, di- esters of fatty food acids and glycerol, triglycerides medium chain, refined soya oil, alpha-tocopherol, gelatin; 85% glycerol.
Fatty degeneration of the liver (including liver damage in diabetes), acute and chronic hepatitis, cirrhosis, pre- and postoperative treatment with surgery of the liver and biliary tract, toxic liver damage, pregnancy toxicosis, radiation syndrome.
Dosage and Administration
Adults and children over 12 years. The initial dose is 2 capsules Enerlivu â 3 times a day and maintenance - 1 capsule 3 times daily.
The drug is used during eating, not chewed and washed down with a sufficient amount of fluid (eg a glass of water).
The recommended duration of treatment is at least 3 months.
Reports of overdose Enerlivu â or intoxication it has not been reported.
You can add first review.